22NW Fund, LP, Insider at Anebulo Pharmaceuticals, Inc. (ANEB), bought 400 shares at $6.59 ($3K) on 2021-12-17, disclosed to the SEC on 2021-12-21.
Open-market purchase of $3k ANEB by Insider. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CULP | BUY | 2025-03-17 | $117K | — | Filing → |
| CULP | BUY | 2025-03-12 | $493K | — | Filing → |
| FSTR | BUY | 2023-05-19 | $690K | — | Filing → |